Suchergebnisse - "Spiekermann, Karsten"

PubPharm (235)

41

Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia

enthalten in: Infection | 2022

von Ruzicka, M. | Wurm, S. | Lindner, L. | +9

42

Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia

enthalten in: Infection | 2022

von Ruzicka, M. | Wurm, S. | Lindner, L. | +9

43

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

enthalten in: Journal of hematology & oncology | 2022

von Kunadt, D. | Stasik, S. | Metzeler, K. | +44

44

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

enthalten in: Journal of hematology & oncology | 2022

von Kunadt, D. | Stasik, S. | Metzeler, K. | +43

45

Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration

enthalten in: Blood | 2022

von Nicolai, L. | Leunig, A. | Pekayvaz, K. | +22

CommentIn: Blood. 2022 Aug 4;140(5):413-414. - PMID 35925641

46

Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with intermediate-risk - results of the randomized ETAL-1 trial

enthalten in: ResearchSquare.com | 2022

von Bornhauser, M. | Schliemann, C. | Schetelig, J. | +26

47

Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia

enthalten in: ResearchSquare.com | 2022

von Ruzicka, M. | Wurm, S. | Lindner, L. | +9

48

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML : results from a large multicenter study

enthalten in: Blood advances | 2022

von Middeke, J. | Metzeler, K. | Röllig, C. | +43

49

Seasonal community acquired respiratory viruses (CARV) are associated with a high burden of disease in patients with malignancies : preliminary data of the OncoReVir registry

enthalten in: Oncology research and treatment | 2022

von Rüthrich, M. | Schmitt, T. | Claßen, A. | +13

50

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody

enthalten in: Blood | 2021

von Augsberger, C. | Hänel, G. | Xu, W. | +33

CommentIn: Blood. 2021 Dec 23;138(25):2598-2599. - PMID 34940819